#USA #New York #Class Action #Legal Rights #Alto Neuroscience

Important Information for Alto Neuroscience Shareholders

In a recent announcement, The Gross Law Firm has reminded shareholders of Alto Neuroscience, Inc. (NYSE: ANRO) about the impending deadline for lead plaintiff applications in an ongoing class action lawsuit. Scheduled for September 19, 2025, this deadline marks a crucial date for investors who acquired shares during the specified class period.

Overview of the Case

This class action lawsuit encompasses shareholders who purchased or acquired Alto common stock pursuant to offerings associated with the company's initial public offering on February 2, 2024, and those who engaged in transactions between February 2, 2024, and October 22, 2024. The allegations center around claims that the defendants provided misleading information regarding the efficacy of the company's product pipeline, specifically ALTO-100, which was purported to treat major depressive disorder. Assertions in the complaint suggest that the claims made about the product's prospects were overstated, both in clinical trials and potential commercial success. This misrepresentation allegedly led to inflated stock prices and significant losses for the shareholders when the truth emerged.

Next Steps for Interested Shareholders

Alto shareholders who believe they have been impacted are encouraged to reach out to The Gross Law Firm for guidance on how to proceed with registration. Participation as a lead plaintiff is not mandatory to join the case; however, potential plaintiffs must register before the deadline to ensure their rights are protected. Upon registration, shareholders will be included in a portfolio monitoring system that will provide ongoing updates regarding the status of the case.

The Role of The Gross Law Firm

The Gross Law Firm is recognized nationally for its commitment to safeguarding investor rights. It aims to assist individuals who have suffered losses due to deceptive practices in the market. Their mission encompasses an array of objectives that include ensuring responsible corporate practices while aiding affected shareholders in recovering losses. Those interested in exploring their options or needing more in-depth information about the class action can contact the firm directly.

Conclusion

Investors of Alto Neuroscience should not delay their registration, as time is of the essence in navigating this legal process. The Gross Law Firm remains dedicated to ensuring that justice is served for all involved parties.

Contact Information:
For more inquiries, please reach out:

• - Address: The Gross Law Firm, 15 West 38th Street, 12th floor, New York, NY, 10018
• - Phone: (646) 453-8903
• - Email: [email protected]

Don’t miss this opportunity to protect your investment rights. Register now before the deadline on September 19, 2025!